SSYA10-001

Pricing Availability   Qty

15% Off Limited-time Savings on Your Reagents, Assays, and Kits
Now through September 27th, you can save 15% on Bio-Techne reagents, assays, and kits (including Novus, Tocris, and R&D Systems). Use promotion code SAVE15 at checkout on orders over $1,000. See terms and conditions for offer details.

Cat.No. 7554 - SSYA10-001 | C12H12N4O2S2 | CAS No. 675104-49-1
Description: Potent coronavirus helicase inhibitor; also inhibits human papillomavirus E6
Chemical Name: 2,4-Dihydro-5-[[(2-nitrophenyl)thio]methyl]-4-(2-propen-1-yl)-3H-1,2,4-triazole-3-thione
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews

Biological Activity for SSYA10-001

SSYA10-001 is a potent coronavirus helicase inhibitor (IC50 values are 0.046 μM and >3 μM for unwinding and ATPase, respectively). Inhibits SARS-CoV-2 Nsp13 helicase (IC50 = 3.5 μM), blocks dsDNA and dsRNA unwinding activities of Nsp13 (IC50 values are 5.3 μM and 5.7 μM respectively). In a SARS-CoV replicon assay SSYA10-001 inhibits (+) sense but not (-) sense RNA synthesis (EC50 = 8.95 μM). Also inhibits human papillomavirus E6 (IC50 = 10 μM)

Technical Data for SSYA10-001

M. Wt 308.37
Formula C12H12N4O2S2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 675104-49-1
PubChem ID 2807230
InChI Key VWFIHGWHMXSTAO-UHFFFAOYSA-N
Smiles C=CCN1C(NN=C1CSC2=C(N(=O)=O)C=CC=C2)=S

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for SSYA10-001

References are publications that support the biological activity of the product.

Adedeji et al (2012) Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob.Agents Chemother. 56 4718 PMID: 22733076

Malecka et al (2014) Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem.Biol. 9 1603 PMID: 24854633

Kumar and Lupoli (2020) Exploiting existing molecular scaffolds for long-term COVID treatment. ACS Med.Chem.Lett. 11 1357 PMID: 32665808

Spratt et al (2021) Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents. Expert Opin.Ther.Pat. 31 339 PMID: 33593200

Nizi et al (2022) Discovery of 2-phenylquinolines with broad-spectrum anti-coronavirus activity. ACS Med.Chem.Lett. 13 855 PMID: 35571875


If you know of a relevant reference for SSYA10-001, please let us know.

Keywords: SSYA10-001, SSYA10-001 supplier, SSYA10001, coronaviruses, helicases, inhibitors, potent, unwinding, ATPase, SARS-CoV-2, nsp13, human, papillomavirus, dsRNA, dsDNA, Coronavirus, Other, Antivirals, DNA,, RNA, and, Protein, Synthesis, 7554, Tocris Bioscience

Citations for SSYA10-001

Citations are publications that use Tocris products.

Currently there are no citations for SSYA10-001. Do you know of a great paper that uses SSYA10-001 from Tocris? Please let us know.

Reviews for SSYA10-001

There are currently no reviews for this product. Be the first to review SSYA10-001 and earn rewards!

Have you used SSYA10-001?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review